Form 4 for NVAX NOVAVAX INC
Accepted 2022-01-04 00:00:00 ET · period of report 2021-12-31 · accession 0001209191-22-000955 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-01-04 | 2021-12-31 | NVAX | YOUNG JAMES F | Dir | M - OptEx | $25.60 | +3,750 | 78.8K | +5% | +$96.0K |
| D | 2022-01-04 | 2021-12-31 | NVAX | YOUNG JAMES F | Dir | S - Sale+OE | $144.16 | -3,750 | 75.1K | -5% | -$540.6K |
| D | 2022-01-04 | 2021-12-31 | NVAX | YOUNG JAMES F | Dir | M - OptEx | $0.00 | -3,750 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-31 | M | A | 3,750 | $25.60 | 78,840 | D | — | — | |
| 2 | Common | Common Stock | 2021-12-31 | S | D | 3,750 | $144.16 | 75,090 | D | — | — | (F1) The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $144.1004 to $144.37, inclusive. The reporting person undertakes to provide to Novavax, Inc., any security holder of Novavax, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote. |
| 3 | Derivative | Stock Option (Right to Buy) | 2021-12-31 | M | D | 3,750 | $0.00 | 0 | D | $25.60 · 2012-09-01 to 2022-03-01 | 3,750 Common Stock |